Increased expression of pAKT is associated with radiation resistance in cervical cancer

British Journal of Cancer

Volumn 94, Issue 11, 2006, Pages 1678-1682

  Kim, T J ^a   Lee, J W ^a   Song, S Y ^a   Choi, J J ^a   Choi, C H ^a   Kim, B G ^a   Lee, J H ^a   Bae, D S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cervical neoplasms; Immunohistochemistry; pAKT; PI3K; Radiation resistance

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADULT; AGED; BEAM THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; RETROSPECTIVE STUDY; REVIEW; SURVIVAL TIME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RADIATION TOLERANCE; RECURRENCE; UTERINE CERVICAL NEOPLASMS;

EID: 33745276511     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603180     Document Type: Review

References (33)

1. Blackhall FH, Pintilie M, Michael M, Leighl N, Feld R, Tsao MS, Shepherd FA (2003) Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer. Clin Cancer Res 9: 2241 - 2247
2. Campbell S, Goessens L, Goswamy R, Whitehead M (1982) Real-time ultrasonography for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer? Lancet 1: 425 - 426
3. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS (2003) Analysis of the phosphatidy-linositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63: 2742 - 2746
4. Chung YM, Kim BG, Park CS, Huh SJ, Kim J, Park JK, Cho SM, Kim BS, Kim JS, Yoo YD, Bae DS (2005) Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 117: 194 - 201
5. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R (2003) Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 159: 283 - 300
6. Gupta AK, Cerniglia GJ, Mick R, Ahmed MS, Bakanauskas VJ, Muschel RJ, McKenna WG (2003) Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. Int J Radiat Oncol Biol Phys 56: 846 - 853
7. Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ (2002) Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 8: 885 - 892
8. Hacker NF (1988) Clinical and operative staging of cervical cancer. Baillieres Clin Obstet Gynaecol 2: 747 - 759
9. Kersemaekers AM, Fleuren GJ, Kenter GG, Van den Broek LJ, Uljee SM, Hermans J, Van de Vijver MJ (1999) Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5: 577 - 586
10. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs III CL, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154 - 1161
11. Lander HM (1997) An essential role for free radicals and derived species in signal transduction. FASEB J 11: 118 - 124
12. Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA (2006) Phosphatidyl-inositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res 12: 250 - 256
13. Lee JE, Huh SJ, Park W, Lim DH, Ahn YC, Park CS, Kim BG, Bae DS, Lee JH, Park CT, Kim TJ, Lim KT, Chung HW, Lee KH, Shim JU (2004) Radical radiotherapy for locally advanced cancer of uterine cervix. Cancer Res Treatment 36: 222 - 227 (Korean only)
14. Lee CM, Shrieve DC, Zempolich KA, Lee RJ, Hammond E, Handrahan DL, Gaffney DK (2005) Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix. Gynecol Oncol 99: 415 - 421
15. Liao Y, Grobholz R, Abel U, Trojan L, Michel MS, Angel P, Mayer D (2003) Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer. Int J Cancer 107: 676 - 680
16. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK, Shen CY (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19: 2739 - 2744
17. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI (2002) Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 8: 1168 - 1171
18. Mathur SP, Mathur RS, Young RC (2000) Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Immunol 44: 222 - 230
19. Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, Anderson KC (2002) Activation of NF-kappaB and upregulation of intracellular antiapoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 21: 5673 - 5683
20. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340: 1137 - 1143
21. Nakano T, Kato S, Ohno T, Tsujii H, Sato S, Fukuhisa K, Arai T (2005) Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103: 92 - 101
22. Nakano T, Oka K, Ishikawa A, Morita S (1997) Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma. Cancer 79: 513 - 520
23. Nasu S, Ang KK, Fan Z, Milas L (2001) C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys 51: 474 - 477
24. Pillai MR, Jayaprakash PG, Nair MK (1998) Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix. J Cancer Res Clin Oncol 124: 456 - 461
25. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144 - 1153
26. Schmitz KJ, Otterbach F, Callies R, Levkau B, Holscher M, Hoffmann O, Grabellus F, Kimmig R, Schmid KW, Baba HA (2004) Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mod Pathol 17: 15 - 21
27. Sen CK, Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10: 709 - 720
28. Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98: 10983 - 10985
29. Vijapurkar U, Kim MS, Koland JG (2003) Roles of mitogen-activated protein kinase and phosphoinositide 3′-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling. Exp Cell Res 284: 291 - 302
30. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489 - 501
31. Waggoner SE (2003) Cervical cancer. Lancet 361: 2217 - 2225
32. Zhan M, Han ZC (2004) Phosphatidylinositide 3-kinase/AKT in radiation responses. Histol Histopathol 19: 915 - 923
33. Zhou BP, Hu MC, Miller SA, Yu Z, Xia W, Lin SY, Hung MC (2000) HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem 275: 8027 - 8031